Cancer screening is an integral component of preventive medicine, aiming to detect malignancies at an early, more treatable stage before symptoms manifest. These screenings involve systematic examinations or tests to identify cancer or precancerous conditions in individuals who may not yet show any signs of the disease. Common cancer screening methods include mammography for breast cancer, Pap smears for cervical cancer, colonoscopies for colorectal cancer, and prostate-specific antigen (PSA) tests for prostate cancer. The goal is to catch abnormalities before they progress, allowing for timely intervention and increased chances of successful treatment. While screening recommendations may vary based on age, gender, and risk factors, the overarching objective is to facilitate early detection, which is a cornerstone of preventive medicine. Regular screenings, coupled with a comprehensive understanding of personal risk factors, empower individuals and healthcare providers to collaborate effectively in managing and mitigating the impact of cancer, aligning with the broader goal of promoting health and well-being through preventive measures.







Title : Change your genes – Change your life: Epigenetics of longevity
Kenneth R Pelletier, University of California, United States
Title : Harmonisation legislation issues in health care public policies to prevent obesity
Iuliana Vintila, Dunarea de Jos University, Galati, Romania